Magnetic Nanomaterials for Drug Delivery and Therapy II
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Nanotechnology and Applied Nanosciences".
Deadline for manuscript submissions: closed (20 November 2022) | Viewed by 516
Special Issue Editor
Interests: protease signatures for early cancer diagnostics and cancer therapy decisions; imaging of biophysical barriers in cancer/spectral imaging/micrometastases; advanced drug delivery and drug delivery materials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We would like to invite you to submit a manuscript to this Special Issue of Applied Sciences, entitled Magnetic Nanomaterials for Drug Delivery and Therapy. Magnetic nanomaterials are constantly evolving towards a higher complexity, and, therefore have an improved efficacy in drug delivery across the blood–brain barrier, to sites of infections, chronic inflammation, and tumors and metastases. Advances in material sciences will be the key to developing efficient drug delivery methodologies. These are urgently needed, because both classic chemotherapy and conventional nanotherapy lead to significant collateral effects, mainly because they cannot deliver drugs efficiently across physiological barriers. Active transport to targeted areas is required to elude these barriers. There is a significant potential for the synergy of nanoparticle-based physical therapies (e.g., hyperthermia or ultrasound) and chemotherapy or immunotherapy. However, to date, they are widely unexplored. In this Issue, nanomaterial-centered approaches to nanotherapy will be discussed. We sincerely hope for a wide variety of technically sound manuscripts in this exciting research area.
Prof. Dr. Stefan Bossmann
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Magnetic nanoparticles
- Drug delivery
- Chemotherapy
- Physical therapy
- Targeted therapy
- Blood–brain barrier
- Infectious disease
- Chronic inflammation
- Solid tumor
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
